Inhibitors

A cell-permeable and reversible quinoxaline compound that potently and selectively inhibits Akt1/Akt2 activity (IC 50 = 58 nM, 210 nM, and 2.12 &#181M for Akt1, Akt2, and Akt3, respectively, in in vitro kinase assays).

A cell-permeable Akti-1/2- (Cat. No.

A highly cell-permeable and water soluble analog of Akt Inhibitor VIII, Isozyme-Selective, Akti-1/2 (Cat. No.

A cell-permeable pyrazolo compound that acts as a potent inhibitor against Akt (IC 50 = 32, 17, and 47 nM against Akt1, Akt2, and Akt3, respectively), PKA (IC 50 = 20 nM), and p70S6K (IC 50 = 85 nM) in an ATP-competitive manner (K i = 18 nM using

A cell permeable diarylamine derivative that acts as a selective, reversible, substrate-binding site directed inhibitor of aldehyde dehydrogenase ALDH3A1 (K i = 4.7 &#181M, IC 50 = 16 &#181M).

Immunogen adducin 2 (beta) Application All Prestige Antibodies Powered by Atlas Antibodies are developed and validated by the Human Protein Atlas (HPA) project and as a result, are supported by the most extensive characterization in the industry.

Specificity HPA003156 reacts with ATP6AP2 which is moderately immunoreactive to the cytoplasm in most normal cells. Strong immunoreaction can be observed in neuronal cells and pancreatic islets, while cells from the bile duct, exocrine pancreatus

Anti-BLVRA biliverdin reductase A, 100ul UN 1687 6.1 PG2

Anti-BLVRA biliverdin reductase A, 25ul UN 1687 6.1 PG2

Immunogen GPN-loop GTPase 2 recombinant protein epitope signature tag (PrEST) Application All Prestige Antibodies Powered by Atlas Antibodies are developed and validated by the Human Protein Atlas (HPA) project and as a result, are supported by the

G-protein signaling modulator 2 (GPSM2) gene encodes a member of a family of proteins that function in the activation of G proteins. It contains 10 leu-gly-asn (LGN) repeats at the N-terminal and four G&#945i/o–Loco (GoLoco) motifs at the

Anti-MT1E metallothionein 1E, 100ul UN 1687 6.1 PG2